Latin America Investor Daily
SEE OTHER BRANDS

Get your fresh news on finance and banking in Latin America

Latin America Investor Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Investor Daily.

Press releases published on May 5, 2025

As Federal Collections Activity Resumes, More Than One in Five Federal Student Loan Borrowers With a Payment Due are Seriously Delinquent

As Federal Collections Activity Resumes, More Than One in Five Federal Student Loan Borrowers With a Payment Due are Seriously Delinquent

CHICAGO, May 05, 2025 (GLOBE NEWSWIRE) -- As the U.S. Department of Education begins resuming collections activities among defaulted borrowers, new research reveals that the number of consumers at risk for default has soared past pre-pandemic levels. These …

IRADIMED CORPORATION Announces First Quarter 2025 Financial Results

IRADIMED CORPORATION Announces First Quarter 2025 Financial Results

Announces Regular Quarterly Cash Dividend of $0.17 Per Share Reaffirms Full Year 2025 Revenue and Earnings Guidance Reports record revenue of $19.5 million for the first quarter of 2025, an increase of $1.9 million or 11%, compared to the same period in …

Dianthus Therapeutics Completes Enrollment of Phase 2 MaGic Trial of DNTH103 in Generalized Myasthenia Gravis With Top-Line Results Expected in September

Dianthus Therapeutics Completes Enrollment of Phase 2 MaGic Trial of DNTH103 in Generalized Myasthenia Gravis With Top-Line Results Expected in September

MaGic trial exceeded enrollment target of 60 patients Top-line results anticipated this September will be the first of three DNTH103 catalysts by YE'26 Building a neuromuscular franchise with DNTH103 in gMG, CIDP and MMN with a potential best-in-class, …

Eupraxia Pharmaceuticals Announces Sustained Positive Treatment Outcomes in Patients with Eosinophilic Esophagitis (EoE) After Nine Months of Receiving EP-104GI

Eupraxia Pharmaceuticals Announces Sustained Positive Treatment Outcomes in Patients with Eosinophilic Esophagitis (EoE) After Nine Months of Receiving EP-104GI

Eupraxia continues to observe positive treatment outcomes in its ongoing Phase 1b/2a trial, including for the first time clinical responses measured 9 months after dosing with EP-104GI At 9 months active drug continued to be released into the esophagus in …

Osisko Metals Intersects 323 Metres Averaging 0.43% Cu at Gaspé Project

Osisko Metals Intersects 323 Metres Averaging 0.43% Cu at Gaspé Project

MONTREAL, May 05, 2025 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the “Company or "Osisko Metals") (TSX-V: OM; OTCQX: OMZNF; FRANKFURT: 0B51) is pleased to announce new drilling results from the 2025 drilling program at the Gaspé Copper Project, …

MTY Food Group Inc. Announces Results from 2025 Annual General Meeting

MTY Food Group Inc. Announces Results from 2025 Annual General Meeting

MONTREAL, May 05, 2025 (GLOBE NEWSWIRE) -- MTY Food Group Inc. (“MTY” or the “Company”) (TSX: MTY), franchisor and operator of multiple concepts of restaurants, is pleased to report the results from the votes from its shareholders for the 2025 Annual …

Métaux Osisko recoupe 323 mètres à une teneur moyenne de 0,43 % cuivre à Mines Gaspé

Métaux Osisko recoupe 323 mètres à une teneur moyenne de 0,43 % cuivre à Mines Gaspé

MONTRÉAL, 05 mai 2025 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (la « Société » ou « Métaux Osisko ») (TSXV : OM; OTCQX : OMZNF; FRANKFURT : 0B51) a le plaisir d’annoncer de nouveaux résultats de forage issus du programme de forage 2025 sur le projet …

Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™

Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™

NEWARK, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL; NYSE American: RFL-WT) today announced revised subscription rights in connection with its previously announced rights offering. Holders of record as of May 9, 2025 (the “ …

ManageMy and Solvrays Enable Insurance Carriers to Automate Workflows and Deliver Better Customer Experiences

ManageMy and Solvrays Enable Insurance Carriers to Automate Workflows and Deliver Better Customer Experiences

CHARLOTTE, N.C., May 05, 2025 (GLOBE NEWSWIRE) -- ManageMy, the platform purpose-built to simplify insurance through superior digital experiences, and Solvrays, an innovator in AI-driven automation for insurance operations, are uniting to help insurance …

Ocular Therapeutix™ Reports First Quarter 2025 Results and Business Highlights

Ocular Therapeutix™ Reports First Quarter 2025 Results and Business Highlights

AXPAXLI™ SOL trials for wet AMD progressing rapidly following recent updates to accelerate and enhance the registrational program Following positive FDA feedback for potential AXPAXLI NPDR registrational trial, Ocular is actively planning next steps in …

Groupe d’Alimentation MTY inc. publie le résultat du vote de ses actionnaires tenu lors de son Assemblée Générale Annuelle 2025

Groupe d’Alimentation MTY inc. publie le résultat du vote de ses actionnaires tenu lors de son Assemblée Générale Annuelle 2025

MONTRÉAL, 05 mai 2025 (GLOBE NEWSWIRE) -- Groupe d'Alimentation MTY inc. (« MTY » ou la « Société ») (TSX: MTY), franchiseur et opérateur de multiples concepts de restaurants, annonce aujourd’hui le résultat du vote de ses actionnaires lors de l’Assemblée …

Axsome Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Axsome Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Total 1Q 2025 net product revenue of $121.5 million, representing 62% year-over-year growth AUVELITY® 1Q 2025 net product sales of $96.2 million, representing 80% year-over-year growth SUNOSI® 1Q 2025 net product revenue of $25.2 million, representing 17% …

TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance

TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance

First quarter 2025 BRIUMVI U.S. net revenue of $119.7 million Raises full year 2025 global net revenue target to approximately $575 million and raises full year BRIUMVI U.S. net revenue target to approximately $560 million Conference call to be held today, …

Update to Zijin Put Option and Exclusivity Arrangements

Update to Zijin Put Option and Exclusivity Arrangements

TORONTO, May 05, 2025 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu or the Company) refers to its announcement dated 7 April 2025 in relation to the Extension of the Zijin Put Option and Exclusivity Arrangements1 with its major …

Pershing Square to Invest $900 million to Acquire Nine Million Newly Issued Shares of Howard Hughes Holdings and Transform HHH Into a Diversified Holding Company

Pershing Square to Invest $900 million to Acquire Nine Million Newly Issued Shares of Howard Hughes Holdings and Transform HHH Into a Diversified Holding Company

Pershing Square to Support HHH’s Strategic Expansion Through Investment, Advisory, and Other Resources HHH Will Operate as a Diversified Holding Company Seeking to Acquire Controlling Interests in High-Quality, Durable Growth Public and Private Companies …

BioNTech veröffentlicht Ergebnisse für das erste Quartal 2025 sowie Informationen zur Geschäftsentwicklung

BioNTech veröffentlicht Ergebnisse für das erste Quartal 2025 sowie Informationen zur Geschäftsentwicklung

Weiterentwicklung der Onkologie-Pipeline vorangetrieben mit strategischem Fokus auf zwei tumorübergreifende (Pan-Tumor-)Programme: Immunmodulator-Kandidat BNT327, ein gegen PD-L1 und VEGF-A1 gerichteter bispezifischer Antikörper, und mRNA- …

BioNTech Announces First Quarter 2025 Financial Results and Corporate Update

BioNTech Announces First Quarter 2025 Financial Results and Corporate Update

Continued oncology pipeline advancement with a strategic focus on two priority pan-tumor programs: next-generation immunomodulator BNT327, a bispecific antibody targeting PD-L1 and VEGF-A1, and mRNA cancer immunotherapies Presented multiple clinical …

K92 Mining Announces the Passing of Board Member, Graham Wheelock

K92 Mining Announces the Passing of Board Member, Graham Wheelock

VANCOUVER, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) -- K92 Mining Inc. (“K92” or the “Company”) (TSX: KNT; OTCQX: KNTNF) announces with tremendous sadness the passing of our fellow director and colleague, Graham Wheelock. Graham served on K92’s …

Freshpet, Inc. Reports First Quarter 2025 Financial Results

Freshpet, Inc. Reports First Quarter 2025 Financial Results

Delivers Approximately 18% Net Sales Growth Strong Operating Performance on Input, Quality and Logistics Costs Updates 2025 Outlook BEDMINSTER, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Freshpet, Inc. (“Freshpet” or the “Company”) (Nasdaq: FRPT) today …

Integra LifeSciences Reports First Quarter 2025 Financial Results

Integra LifeSciences Reports First Quarter 2025 Financial Results

PRINCETON, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2025. First Quarter 2025 …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service